Novasign Announces Strategic Partnership with Repligen to Further Advance Bioprocessing Digitalization Read More
Novasign Logo
  • Home
  • About Us
    • Team
    • History
    • Mission and Vision
    • Advisory Board
    • Strategic Partners
  • Solutions
    • Novasign for CDMOs
    • Novasign for Biopharma
    • Novasign for Industrial Biotech
  • Services
    • Bioprocess Modeling
    • Process Development
    • Software Training
  • Products
    • Novasign Studio
    • Hybrid Modeling Toolbox
    • Digital Twin
  • Technology
  • Resources
    • Blog
    • News & Publications
    • Events & Webinars
    • FAQs
    • Documentation
  • Careers
  • Contact Us

Portal

Icon-x Linkedin-in Youtube
Login
Novasign Icon
  • Home
  • About Us
    • Team
    • History
    • Mission and Vision
    • Advisory Board
    • Strategic Partners
  • Solutions
    • Novasign for CDMOs
    • Novasign for Biopharma
    • Novasign for Industrial Biotech
  • Services
    • Bioprocess Modeling
    • Process Development
    • Software Training
  • Products
    • Novasign Studio
    • Hybrid Modeling Toolbox
    • Digital Twin
  • Technology
  • Resources
    • Blog
    • News & Publications
    • Events & Webinars
    • FAQs
    • Documentation
  • Careers
  • Contact Us

Portal

Login
  • Home
  • About Us
    • Team
    • History
    • Mission and Vision
    • Advisory Board
    • Strategic Partners
  • Solutions
    • Novasign for CDMOs
    • Novasign for Biopharma
    • Novasign for Industrial Biotech
  • Services
    • Bioprocess Modeling
    • Process Development
    • Software Training
  • Products
    • Novasign Studio
    • Hybrid Modeling Toolbox
    • Digital Twin
  • Technology
  • Resources
    • Blog
    • News & Publications
    • Events & Webinars
    • FAQs
    • Documentation
  • Careers
  • Contact Us
logotype
logotype
  • Home
  • About Us
    • Team
    • History
    • Mission and Vision
    • Advisory Board
    • Strategic Partners
  • Solutions
    • Novasign for CDMOs
    • Novasign for Biopharma
    • Novasign for Industrial Biotech
  • Services
    • Bioprocess Modeling
    • Process Development
    • Software Training
  • Products
    • Novasign Studio
    • Hybrid Modeling Toolbox
    • Digital Twin
  • Technology
  • Resources
    • Blog
    • News & Publications
    • Events & Webinars
    • FAQs
    • Documentation
  • Careers
  • Contact Us
Blog Post
Home Bioprocessing Europe Lisbon

Bioprocessing Europe Lisbon

Updated: Apr 10, 2020

Last week we have been to Bioprocessing Europe in Lisbon. The conference was organized in a brought manner, offering both, an up- and downstream processing stream, as well as a gene and cell therapy stream. With more than 100 experts presenting their current bleeding and cutting edge technology, the conference, hosted in the Sheraton Lisboa Hotel & Spa, was a great deal. We were also presenting the recent progress with our technology. While Gerald Striedner was introducing the latest updates in soft sensor development for upstream technologies, Moritz and I were highlighting the need to step away from static process descriptions towards dynamic process models.

Why should the whole dynamics of a bioprocess only be described at the endpoint of a process? Why not incorporate process variables over time and additionally use hybrid model approaches to also get a better process understanding from prior process knowledge. Let me bring a provocative comparison: For us, the current status in upstream development is somehow similar to cooking pasta! Why?

Why do we still describe dynamic bioprocesses with static approaches? The time to change has come!

If you look at the package of a certain type of noodles, it will tell you how long the pasta has to be cooked until the perfect quality (“al dente”) is delivered. However, the whole complexity of the process is neglected. It is just assumed that when you keep the water temperature constant, your pasta quality will hit the sweet spot after the described “process time”. But how is this different from bioprocess development? In upstream development, a lot of parameters are currently screened in complex design of experiments (DoE) worldwide. However, the product quality (titer, glycosylation patterns, host cell content, remaining DNA and others) is only described for the process endpoint. But what if process deviations occur? What if, to get back to the noodle example, the heating system fails? Your noodle quality will not be in the desired space, because the process itself is not understood! If you do process development with DoE you most probably have to repeat the experiment because you assumed that the temperature was kept constant.

Comparison of static process description with classic DoE and dynamic process description using Novasign's hybrid models - Bioprocessing Europe Lisbon

Comparison of static process description with classic DoE and dynamic process description using hybrid models. While the classic DoE approach only evaluates a certain process at the endpoint, the hybrid model approach incorporates every time point. Hence, also process deviations are used to build the final model

So in our approach, we incorporate the process data and build a hybrid model based on the whole process. Hence, if a certain parameter changes over time (let us assume the temperature control fails for two to three hours) this information is used to build the model, thus also enabling model predictive control.

Apart from the four talks we presented, we also got the chance to share our insights in a workshop. Although we are constantly presenting our approach to dynamically describe bioprocesses on quite a lot of conferences, the feedback is still refreshing and we obtain a lot of requests of companies to help them set up those strategies.

Apart from the highly productive conference, also Lisbon is always worth a visit. With its hilly terrain, the historic center, the cable cars, and the Mediterranean cuisine it feels like a mixture of Rome, Vienna, and San Francisco. Whenever the next opportunity will arise, we will come back.

“Até breve Lisboa”

Novasign attended the Bioprocessing Europe Conference in Lisbon

It’s quite though to describe the beauty of a city in a single picture 🙂 But I tried my best. Here you can see: Rua Augusta Arch which was built to remember the city’s reconstruction after the earthquake of 1755

Reducing the costs of biopharmaceuticals: a bioprocess development approach

November 7, 2018

Novasign at the Vienna City Marathon 2019

April 9, 2019
Novasign at the Vienna City Marathon 2019

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts
  • De‑Risking Bioprocess Scale‑Up: Predictive Modeling for Reliable Fermentation and Cell Culture Manufacturing
  • Autonomous Continuous Biomanufacturing: Closing the Gap Between Process Development and Production
  • Next‑Generation Media Development: How Modeling Reduces Cost and Accelerates Bioprocess Optimization
Categories
  • Bioprocess9
  • Bioprocess Development10
  • Biotechnology12
  • Digital Twin5
  • FDA1
  • Hybrid Modeling9
  • Modeling5
  • Quality by Design3
  • Reducing Costs6
  • Uncategorized6
Tags
Antibodies ATMP bioprocess bioprocessing biotechnology CFD chemometrics co-creation conference data Diafiltration Filtration hybrid modeling MonoclonalAntibodies partnership pharma4.0 process modeling soft sensor team building Ultrafiltration vienna city marathon
Log in
Novasign Bioprocessing Logo White Outlined

About Us

Novasign

Team

History

Mission and Vision

Advisory Board

Partners

Products

Novasign Studio

Hybrid Modeling ToolboxDigital Twin

Services

Bioprocess Modeling

Process Development

Software Training 

Technology

Process ModelingDigital TwinSmart Experimental DesignEconomic Process Predictor

Resources

BlogNews and PublicationEvents and WebinarsFAQs

CareersDocumentation

Contact

Contact Us

Bookings

Imprint

Privacy Policy

 

© Novasign GmbH

Linkedin Icon-x Youtube

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.